These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 12886549)

  • 1. [The Steno-2 study. Intensive multifactorial intervention reduces the occurrence of cardiovascular disease in patients with type 2 diabetes].
    Gaede PH; Jepsen PV; Larsen JN; Jensen GV; Parving HH; Pedersen OB
    Ugeskr Laeger; 2003 Jun; 165(26):2658-61. PubMed ID: 12886549
    [No Abstract]   [Full Text] [Related]  

  • 2. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes.
    Gaede P; Vedel P; Larsen N; Jensen GV; Parving HH; Pedersen O
    N Engl J Med; 2003 Jan; 348(5):383-93. PubMed ID: 12556541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Target intervention against multiple-risk markers to reduce cardiovascular disease in patients with type 2 diabetes.
    Gaede P; Pedersen O
    Ann Med; 2004; 36(5):355-66. PubMed ID: 15478310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing cardiovascular risk in patients with diabetes.
    Rydén L
    Heart; 2000 Sep; 84 Suppl 1(Suppl 1):i23-5:discussion i50. PubMed ID: 10956316
    [No Abstract]   [Full Text] [Related]  

  • 5. Regarding "Pharmacologic risk factor management in peripheral arterial disease: a vade mecum for vascular surgeons".
    Paraskevas KI
    J Vasc Surg; 2008 Sep; 48(3):776-7; author reply 777. PubMed ID: 18727983
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of type 2 diabetes mellitus to reduce cardiovascular morbidity and mortality: a review of the evidence.
    Giles TD
    J Clin Hypertens (Greenwich); 2009 Sep; 11(9):512-9. PubMed ID: 19751467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular Risk and Risk Factor Management in Type 2 Diabetes Mellitus: A Population-Based Cohort Study Assessing Sex Disparities.
    Wright AK; Kontopantelis E; Emsley R; Buchan I; Mamas MA; Sattar N; Ashcroft DM; Rutter MK
    Circulation; 2019 Jun; 139(24):2742-2753. PubMed ID: 30986362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating the cardiometabolic syndrome: an opportunity to provide comprehensive cardiovascular risk reduction.
    Basile J; Houston M; Ferrario CM
    J Cardiometab Syndr; 2006; 1(5):358-61. PubMed ID: 17679795
    [No Abstract]   [Full Text] [Related]  

  • 9. ["Diabetes in Germany"(DIG) study. A prospective 4-year-follow-up study on the quality of treatment for type 2 diabetes in daily practice].
    Ott P; Benke I; Stelzer J; Köhler C; Hanefeld M
    Dtsch Med Wochenschr; 2009 Feb; 134(7):291-7. PubMed ID: 19197810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reducing cardiovascular risk in type 2 diabetes.
    Solomon CG
    N Engl J Med; 2003 Jan; 348(5):457-9. PubMed ID: 12556548
    [No Abstract]   [Full Text] [Related]  

  • 11. Implications of the United Kingdom Prospective Diabetes Study (UKPDS) results on patient management.
    Nicollerat JA
    Diabetes Educ; 2000; 26 Suppl():8-10. PubMed ID: 11912816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of a multifactorial intervention on mortality in type 2 diabetes.
    Gaede P; Lund-Andersen H; Parving HH; Pedersen O
    N Engl J Med; 2008 Feb; 358(6):580-91. PubMed ID: 18256393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of individual life-years gained without cardiovascular events from lipid, blood pressure, glucose, and aspirin treatment based on data of more than 500 000 patients with Type 2 diabetes mellitus.
    Berkelmans GFN; Gudbjörnsdottir S; Visseren FLJ; Wild SH; Franzen S; Chalmers J; Davis BR; Poulter NR; Spijkerman AM; Woodward M; Pressel SL; Gupta AK; van der Schouw YT; Svensson AM; van der Graaf Y; Read SH; Eliasson B; Dorresteijn JAN
    Eur Heart J; 2019 Sep; 40(34):2899-2906. PubMed ID: 30629157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is treatment of hypertension with acetylcholine esterase inhibitors (ACEIs) superior to other antihypertensives in preventing significant cardiovascular events and death in patients with type 2 diabetes?
    McConaghy JR
    J Fam Pract; 2000 Nov; 49(11):980. PubMed ID: 11093559
    [No Abstract]   [Full Text] [Related]  

  • 15. [Renin-angiotensin system blockade reduces cardiovascular mortality and morbidity attributable to arterial hypertension by primary and secondary prevention. The end of the road?].
    Coca A; Ruilope LM
    Med Clin (Barc); 2000 Jul; 115(5):178-80. PubMed ID: 10996874
    [No Abstract]   [Full Text] [Related]  

  • 16. Case 2. Recurrence of myocardial infarction.
    Tanser P; Archer S; Feldman R
    Can J Cardiol; 2000 Aug; 16 Suppl E():24E-26E. PubMed ID: 10906622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Overview of cardiovascular risk factors].
    De la Figuera von Wichmann M; Llisterri Caro JL
    Med Clin (Barc); 2006 Nov; 127(20):774-5. PubMed ID: 17198664
    [No Abstract]   [Full Text] [Related]  

  • 18. Is global cardiovascular risk considered in current practice? Treatment and control of hypertension, hyperlipidemia, and diabetes according to patients' risk level.
    Roccatagliata D; Avanzini F; Monesi L; Caimi V; Lauri D; Longoni P; Marchioli R; Tombesi M; Tognoni G; Roncaglioni MC;
    Vasc Health Risk Manag; 2006; 2(4):507-14. PubMed ID: 17323606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Management of patients with essential hypertension. Clinical recommendations and economic data. Guidelines April 2000. Recommendations of the ANAES].
    Agence Nationale d'Accréditation et d'Evaluation en Santé
    J Mal Vasc; 2000 Dec; 25(5):366-376. PubMed ID: 11148400
    [No Abstract]   [Full Text] [Related]  

  • 20. Aggressive antihypertensive treatment and serum lipid lowering therapy are necessary to prevent deterioration of the renal function even in elderly type 2 diabetic patients with persistent albuminuria.
    Narita T; Kakei M; Ito S
    Gerontology; 2002; 48(5):302-8. PubMed ID: 12169796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.